Vidhun Jayakumar, Masciandro Jim, Varich Laura, Salvatierra Oscar, Sarwal Minnie
Department of Pediatrics, Stanford University, Palo Alto, California 94304, USA.
Transplantation. 2003 Aug 15;76(3):552-7. doi: 10.1097/01.TP.0000076097.90123.21.
Allograft biopsies are the gold standard for evaluating renal graft dysfunction. Adult-sized kidney (ASK) allografts are placed extraperitoneally in older children and adults and transperitoneally in infant recipients. Transperitoneal graft biopsies may be accompanied by a greater risk of bleeding and bowel injury, although no standardized pediatric study of procedure risk relating to transplant placement exists.
A retrospective single-center study of 328 consecutive ASK biopsies (277 extraperitoneal and 51 transperitoneal) performed since 1995 was conducted to stringently categorize all identified biopsy procedure complications (bleeding, transfusion requirement, bowel perforation, surgical intervention, and graft loss) relating to allograft placement, surveillance versus protocol biopsies, recipient age, and biopsy needle use, with risk stratification and recommendations for improving procedure safety. Two distinct methods of real-time ultrasound guidance were used.
The overall incidence of all adverse effects was 16.1%, with perinephric hematomas accounting for 13.4% and gross hematuria accounting for 2.7%. Hematomas less than 1 cm accounted for 81.4% of all hematomas. Complications of transperitoneal biopsies (using a modified patient placement approach) paralleled those seen in extraperitoneally placed allografts (15.7% vs. 15.5%, P=0.976). Hematomas occurred more frequently (17.8% vs. 8.3%, P=0.010) in clinically indicated versus surveillance biopsies and with 16- versus 18-gauge biopsy needle use (43% vs. 13.3%, P=0.19).
Pediatric allograft ASK biopsies can be performed with minimal adverse outcomes. Transperitoneal ASK placement is not a contraindication for percutaneous biopsy. Strategies to improve biopsy safety include recommendations for patient positioning for transperitoneal ASKs, improved techniques for real-time ultrasound guidance, and use of finer gauge needles.
同种异体肾活检是评估肾移植功能障碍的金标准。成人尺寸的肾脏(ASK)同种异体移植物在大龄儿童和成人中置于腹膜外,在婴儿受者中置于腹膜内。经腹膜肾活检可能伴有更高的出血和肠损伤风险,尽管尚无关于与移植位置相关的手术风险的标准化儿科研究。
对自1995年以来进行的328例连续ASK活检(277例腹膜外活检和51例经腹膜活检)进行回顾性单中心研究,以严格分类所有确定的与同种异体移植位置、监测活检与方案活检、受者年龄以及活检针使用相关的活检手术并发症(出血、输血需求、肠穿孔、手术干预和移植物丢失),并进行风险分层以及提出改善手术安全性的建议。使用了两种不同的实时超声引导方法。
所有不良反应的总发生率为16.1%,肾周血肿占13.4%,肉眼血尿占2.7%。小于1厘米的血肿占所有血肿的81.4%。经腹膜活检(采用改良的患者放置方法)的并发症与腹膜外放置的同种异体移植物的并发症相似(15.7%对15.5%,P = 0.976)。临床指征活检中血肿的发生率高于监测活检(17.8%对8.3%,P = 0.010),使用16号活检针时血肿发生率高于18号活检针(43%对13.3%,P = 0.19)。
儿科同种异体ASK活检的不良后果最小。经腹膜ASK放置不是经皮活检的禁忌证。改善活检安全性的策略包括经腹膜ASK患者定位的建议、实时超声引导技术的改进以及使用更细规格的活检针。